Citation Impact
Citing Papers
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 1: Acute and Continuation Treatment of Major Depressive Disorder
2002
Should pharmacogenetics be incorporated in major depression treatment? Economic evaluation in high- and middle-income European countries
2011
Acute and Longer-Term Outcomes in Depressed Outpatients Requiring One or Several Treatment Steps: A STAR*D Report
2006 Standout
Correlation of CYP2B6, CYP2C19, ABCC4 and SOD2 genotype with outcomes in allogeneic blood and marrow transplant patients
2011
Dose escalation for insufficient response to standard-dose selective serotonin reuptake inhibitors in major depressive disorder
2006
Depression
2018 Standout
Review article: monitoring of immunomodulators in inflammatory bowel disease
2005
The Pharmacogenetics of Immunosuppression for Organ Transplantation
2003
Improving the Prediction of Treatment Response in Depression:Integration of Clinical, Cognitive, Psychophysiological, Neuroimaging, and Genetic Measures
2008
Polymorphism of human cytochrome P450 enzymes and its clinical impact
2009
Impaired expression of CYP2D6 in intermediate metabolizers carrying the *41 allele caused by the intronic SNP 2988G>A: evidence for modulation of splicing events
2006
Cytochrome P-450 Polymorphisms and Response to Clopidogrel
2008 Standout
Utility of CD127 combined with FOXP3 for identification of operational tolerance after liver transplantation
2016 StandoutNobel
Codeine Intoxication Associated with Ultrarapid CYP2D6 Metabolism
2004
Genetic variability of drug-metabolizing enzymes: the dual impact on psychiatric therapy and regulation of brain function
2012
CYP2D6,SULT1A1andUGT2B17Copy Number Variation: Quantitative Detection by Multiplex PCR
2011
Mitochondrial DNA polymerase-γ and human disease
2006
Is dose escalation of antidepressants a rational strategy after a medium–dose treatment has failed?
2005
Be smart, exercise your heart: exercise effects on brain and cognition
2007 Standout
An Overview of Psychotropic Drug-Drug Interactions
2005
In Vivo Quantitative Prediction of the Effect of Gene Polymorphisms and Drug Interactions on Drug Exposure for CYP2C19 Substrates
2013
Influence of cytochrome P450 polymorphisms on drug therapies: Pharmacogenetic, pharmacoepigenetic and clinical aspects
2007
Attitudes to vaccination: A critical review
2014 Standout
Preventing or reducing late side effects of radiation therapy: radiobiology meets molecular pathology
2006 Standout
Functional pharmacogenetics/genomics of human cytochromes P450 involved in drug biotransformation
2008
Clinical Pharmacokinetics and Pharmacodynamics of Tacrolimus in Solid Organ Transplantation
2004 Standout
Pharmacogenomics
2004
Pharmacogenetics of Antidepressants
2011
Pharmacokinetics and Clinical Efficacy of Cyclosporine Treatment of Dogs with Steroid-Refractory Inflammatory Bowel Disease
2006
Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis
2009 Standout
Structure, function, regulation and polymorphism and the clinical significance of human cytochrome P450 1A2
2009
De novo design of a fluorescence-activating β-barrel
2018 StandoutNatureNobel
Pharmacogenetics-Based Population Pharmacokinetic Analysis of Efavirenz in HIV-1-Infected Individuals
2009
Pharmacogenetics of bipolar disorder
2002
Fab Antibody Fragments
2004
New developments in the immunosuppressive drug monitoring of cyclosporine, tacrolimus, and azathioprine
2001
The AmpliChip CYP450 test: cytochrome P450 2D6 genotype assessment and phenotype prediction
2008
The Endophenotype Concept in Psychiatry: Etymology and Strategic Intentions
2003 Standout
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
2015 Standout
Applications of AmpliChip??? CYP450
2005
Clinical Utility of Free Drug Monitoring
2002
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
2013 Standout
Endoscopic, Biopsy, and Histopathologic Guidelines for the Evaluation of Gastrointestinal Inflammation in Companion Animals
2010 Standout
The Use of Therapeutic Drug Monitoring to Optimise Immunosuppressive Therapy
1996
Bioluminescent sensor proteins for point-of-care therapeutic drug monitoring
2014 StandoutNobel
Immunosuppressive Drugs for Kidney Transplantation
2004 Standout
Computational design of ligand-binding proteins with high affinity and selectivity
2013 StandoutNatureNobel
Management of Crohn's Disease in Adults
2009 Standout
Potential Genetic Causes of Heterogeneity of Treatment Effects
2007
Factors affecting operational tolerance after pediatric living-donor liver transplantation: impact of early post-transplant events and HLA match*
2011 StandoutNobel
DNA Microarray Technology in the Clinical Environment:The AmpliChip CYP450 Test for CYP2D6 and CYP2C19 Genotyping
2009
Pharmacokinetics and Clinical Efficacy of Cyclosporine Treatment of Dogs with Steroid‐Refractory Inflammatory Bowel Disease
2006
The Drugs Don't Work
2003
Anticalins: Exploiting a non‐Ig scaffold with hypervariable loops for the engineering of binding proteins
2013
Historical Perspective of Traditional Indigenous Medical Practices: The Current Renaissance and Conservation of Herbal Resources
2014 Standout
Cardiovascular effects of Danshen
2007 Standout
Containing the Atom: Sociotechnical Imaginaries and Nuclear Power in the United States and South Korea
2009 Standout
The sociology of expectations in science and technology
2006 Standout
Association of HTR2C , But Not LEP or INSIG2 , Genes with Antipsychotic-Induced Weight Gain in a German Sample
2010
The Politics of Personalised Medicine: Pharmacogenetics in the Clinic
2004
Analytical error and interference in immunoassay: minimizing risk
2011
Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care
2011 Standout
Pharmacogenetic testing among patients with mood and anxiety disorders is associated with decreased utilization and cost: A propensity-score matched study
2018 StandoutNobel
Practice Guideline for the Treatment of Patients With Obsessive-Compulsive Disorder
2008 Standout
A review of depression and suicide risk assessment using speech analysis
2015 Standout
Rapid Liquid Chromatography–Tandem Mass Spectrometry Routine Method for Simultaneous Determination of Sirolimus, Everolimus, Tacrolimus, and Cyclosporin A in Whole Blood
2002
Guidelines for the management of thyroid cancer
2014 Standout
Developing a framework for responsible innovation
2013 Standout
Personalized Therapy in Pain Management: Where Do We Stand?
2010
Works of Werner Steimer being referenced
Acute Valproate Poisoning
2005
Doxepin Plasma Concentrations: Is There Really a Therapeutic Range?
2001
Effect of adjunctive paroxetine on serum levels and side-effects of tricyclic antidepressants in depressive inpatients
2000
Intravenous application of an anticalin dramatically lowers plasma digoxin levels and reduces its toxic effects in rats
2012
Pharmacogenetics: a new diagnostic tool in the management of antidepressive drug therapy
2001
DRD4 48 bp VNTR but not 5-HT2C Cys23Ser receptor polymorphism is related to antipsychotic-induced weight gain
2008
Evaluation of the AxSYM CyA assay compared with HPLC, TDx monoclonal and EMIT with both pretreatments
1998
Pharmacogenetic screening and therapeutic drugs
2002
Pharmacogenetics and olanzapine treatment: CYP1A2*1F and serotonergic polymorphisms influence therapeutic outcome
2009
TaqMan real-time PCR quantification strategy of CYP2D6 gene copy number for the LightCycler 2.0
2009
Amitriptyline or Not, That Is the Question: Pharmacogenetic Testing of CYP2D6 and CYP2C19 Identifies Patients with Low or High Risk for Side Effects in Amitriptyline Therapy
2005
Optimized Strategy for Rapid Cytochrome P450 2D6 Genotyping by Real-Time Long PCR
2003
Customized Mycophenolate Dosing Based on Measuring Inosine-Monophosphate Dehydrogenase Activity Significantly Improves Patients' Outcomes After Renal Transplantation
2010
Clinical evaluation and therapeutic range of cyclosporine A as monitored by FPIA in kidney transplantation.
1990
Serotonin Transporter Polymorphisms and Side Effects in Antidepressant Therapy – A Pilot Study
2006
Allele-Specific Change of Concentration and Functional Gene Dose for the Prediction of Steady-State Serum Concentrations of Amitriptyline and Nortriptyline in CYP2C19 and CYP2D6 Extensive and Intermediate Metabolizers
2004
Digoxin Assays: Frequent, Substantial, and Potentially Dangerous Interference by Spironolactone, Canrenone, and Other Steroids
2002
Performance and Specificity of Monoclonal Immunoassays for Cyclosporine Monitoring: How Specific Is Specific?
1999